BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 36531670)

  • 1. Immune thrombocytopenia and COVID-19 vaccination: Outcomes and comparisons to prepandemic patients.
    Choi PY; Hsu D; Tran HA; Tan CW; Enjeti A; Chen VMY; Merriman E; Yong ASM; Simpson J; Gardiner E; Cherbuin N; Curnow J; Pepperell D; Bird R
    Res Pract Thromb Haemost; 2023 Jan; 7(1):100009. PubMed ID: 36531670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune thrombocytopenia following immunisation with Vaxzevria ChadOx1-S (AstraZeneca) vaccine, Victoria, Australia.
    Gordon SF; Clothier HJ; Morgan H; Buttery JP; Phuong LK; Monagle P; Chunilal S; Wood EM; Tran H; Szer J; Crawford NW;
    Vaccine; 2021 Nov; 39(48):7052-7057. PubMed ID: 34756770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ChAdOx1 nCoV-19 vaccine-associated thrombocytopenia: three cases of immune thrombocytopenia after 107 720 doses of ChAdOx1 vaccination in Thailand.
    Uaprasert N; Panrong K; Tungjitviboonkun S; Dussadee K; Decharatanachart P; Kaveevorayan P; Shoosanglertwijit R; Watanaboonyongcharoen P; Bunworasate U; Rojnuckarin P
    Blood Coagul Fibrinolysis; 2022 Jan; 33(1):67-70. PubMed ID: 34483267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Case Report of Immune Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination.
    Kim G; Choi EJ; Park HS; Lee JH; Lee JH; Lee KH
    J Korean Med Sci; 2021 Nov; 36(43):e306. PubMed ID: 34751013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secondary Immune Thrombocytopenia (ITP) Associated with ChAdOx1 Covid-19 Vaccination - A Case Report.
    Koch M; Fuld S; Middeke JM; Fantana J; von Bonin S; Beyer-Westendorf J
    TH Open; 2021 Jul; 5(3):e315-e318. PubMed ID: 34377889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment, outcome and re-vaccination of patients with SARS-CoV-2 vaccine-associated immune thrombocytopenia.
    Ruzicka M; Wurm S; Lindner L; Dreyling M; von Bergwelt-Baildon M; Boeck S; Giessen-Jung C; Milani V; Stemmler JH; Subklewe M; Weigert O; Spiekermann K
    Infection; 2023 Feb; 51(1):231-238. PubMed ID: 36195695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune thrombocytopenic purpura secondary to COVID-19 vaccination: A systematic review.
    Bidari A; Asgarian S; Pour Mohammad A; Naderi D; Anaraki SR; Gholizadeh Mesgarha M; Naderkhani M
    Eur J Haematol; 2023 Apr; 110(4):335-353. PubMed ID: 36562217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19 vaccination in patients with immune thrombocytopenia.
    Visser C; Swinkels M; van Werkhoven ED; Croles FN; Noordzij-Nooteboom HS; Eefting M; Last-Koopmans SM; Idink C; Westerweel PE; Santbergen B; Jobse PA; Baboe F; ; Te Boekhorst PAW; Leebeek FWG; Levin MD; Kruip MJHA; Jansen AJG
    Blood Adv; 2022 Mar; 6(6):1637-1644. PubMed ID: 34941989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exacerbation of immune thrombocytopenia following initial and booster vaccination with Pfizer-BioNTech COVID-19 vaccine.
    Aharoni M; Leader A; Shochat T; Raanani P; Spectre G
    Platelets; 2022 Jul; 33(5):781-786. PubMed ID: 35536172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Systematic Review of Reported Cases of Immune Thrombocytopenia after COVID-19 Vaccination.
    Saluja P; Amisha F; Gautam N; Goraya H
    Vaccines (Basel); 2022 Sep; 10(9):. PubMed ID: 36146522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccine-induced immune thrombotic thrombocytopenia after COVID-19 vaccination: Description of a series of 39 cases in Brazil.
    Mouta Nunes de Oliveira P; Mendes-de-Almeida DP; Bertollo Gomes Porto V; Crespo Cordeiro C; Vitiello Teixeira G; Saraiva Pedro R; Roberto Gomes Takey P; Kegele Lignani L; Reis Xavier J; Cardoso Doria da Gama V; Amorim Filho L; Emoingt Furtado B; Santa Maria A; Dahrug Barros T; Neves Waite Freitas L; Dos Santos Pereira T; Lima Abreu D; Bernardes Ramos M; Gabe C; Arnold D; William Smith J; Nazy I; Lourdes de Sousa Maia M;
    Vaccine; 2022 Aug; 40(33):4788-4795. PubMed ID: 35779962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19 vaccination associated severe immune thrombocytopenia.
    Shah SRA; Dolkar S; Mathew J; Vishnu P
    Exp Hematol Oncol; 2021 Jul; 10(1):42. PubMed ID: 34266487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SARS-CoV-2 vaccination and ITP in patients with de novo or preexisting ITP.
    Lee EJ; Beltrami-Moreira M; Al-Samkari H; Cuker A; DiRaimo J; Gernsheimer T; Kruse A; Kessler C; Kruse C; Leavitt AD; Lee AI; Liebman HA; Newland AC; Ray AE; Tarantino MD; Thachil J; Kuter DJ; Cines DB; Bussel JB
    Blood; 2022 Mar; 139(10):1564-1574. PubMed ID: 34587251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New presentations and exacerbations of immune thrombocytopenia after coronavirus disease 2019 vaccinations: the Taiwan experience.
    Chou SC; Chang YC; Liao CK; Chen TC; Sun KJ; Huang WH; Wu YF
    Platelets; 2022 May; 33(4):531-535. PubMed ID: 35196955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety, reactogenicity, and immunogenicity of homologous and heterologous prime-boost immunisation with ChAdOx1 nCoV-19 and BNT162b2: a prospective cohort study.
    Hillus D; Schwarz T; Tober-Lau P; Vanshylla K; Hastor H; Thibeault C; Jentzsch S; Helbig ET; Lippert LJ; Tscheak P; Schmidt ML; Riege J; Solarek A; von Kalle C; Dang-Heine C; Gruell H; Kopankiewicz P; Suttorp N; Drosten C; Bias H; Seybold J; ; Klein F; Kurth F; Corman VM; Sander LE
    Lancet Respir Med; 2021 Nov; 9(11):1255-1265. PubMed ID: 34391547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Post-SARS-CoV-2-vaccination cerebral venous sinus thrombosis: an analysis of cases notified to the European Medicines Agency.
    Krzywicka K; Heldner MR; Sánchez van Kammen M; van Haaps T; Hiltunen S; Silvis SM; Levi M; Kremer Hovinga JA; Jood K; Lindgren E; Tatlisumak T; Putaala J; Aguiar de Sousa D; Middeldorp S; Arnold M; Coutinho JM; Ferro JM
    Eur J Neurol; 2021 Nov; 28(11):3656-3662. PubMed ID: 34293217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immune thrombocytopenia after BNT162b2 mRNA COVID-19 vaccination].
    Matsumura A; Katsuki K; Akimoto M; Sakuma T; Nakajima Y; Miyazaki T; Fujisawa S; Nakajima H
    Rinsho Ketsueki; 2021; 62(11):1639-1642. PubMed ID: 34866090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccine-induced immune thrombotic thrombocytopenia and cerebral venous sinus thrombosis post COVID-19 vaccination; a systematic review.
    Sharifian-Dorche M; Bahmanyar M; Sharifian-Dorche A; Mohammadi P; Nomovi M; Mowla A
    J Neurol Sci; 2021 Sep; 428():117607. PubMed ID: 34365148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Severe thrombocytopenia after COVID-19 mRNA vaccination].
    Hagihara M; Uchida T; Inoue M; Ohara S; Imai Y
    Rinsho Ketsueki; 2021; 62(12):1684-1687. PubMed ID: 35022337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune Thrombocytopenia Onset and Relapse During the COVID-19 Pandemic. A Monocenter Study.
    Auteri G; Paglia S; Mazzoni C; Biondo M; Venturi M; Romagnoli AD; Bartoletti D; Cavo M; Vianelli N; Palandri F
    Mediterr J Hematol Infect Dis; 2023; 15(1):e2023029. PubMed ID: 37180204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.